Prof. Haberkorn honoured with the Georg-von-Hevesy Medal
Prof. Uwe Haberkorn received the Georg-von-Hevesy Medal at the 64th Annual Meeting of the German Society of Nuclear Medicine (DGN). With this award,…
News on lung cancer screening: TLRC's involvement and research
On 1 April, Germany launched its lung cancer screening programme for heavy, long-term smokers. The new initiative is designed to support the detection…
Euro-BioImaging Scientific Ambassador 2026: DZL Academy Fellow Claudia V. Benke
I am very pleased to have been selected as a Scientific Ambassador of Euro-BioImaging for 2026, as one of 11 scientists from across Europe chosen for…
TLRC Scientist Selected for Prestigious DFG Early Career Academy in Medical Technology
Dr. Carley Stewart, from the Department of Diagnostic and Interventional Radiology at Heidelberg University Hospital, has been selected to participate…
Funding for Heidelberg DZL Early-Career Scientist Dr. Niclas Hagen
Mukoviszidose e.V. is supporting the research of Dr. Niclas Hagen, an early-career scientist at the Translational Lung Research Center Heidelberg…
Bioinformatics online tool improves accuracy in staging of multiple lung tumors
Heidelberg researchers validate IASLC test approach for routine clinical use and provide free online tool worldwide
Immunotherapy before lung cancer surgery shows promising results
A team of researchers from the DZL at the Translational Lung Research Center Heidelberg (TLRC) has explored the effectiveness of pembrolizumab, an…
![[Translate to English:]](/fileadmin/_processed_/9/8/csm_AdobeStock_1665016473_13e077dfe5.jpeg "[Translate to English:]")
New insights into ALK fusion variants and their impact on treatment success in lung cancer
A collaborative study by scientists from the TLRC and Stanford University provides new insights into ALK fusion variants and their impact on treatment…